Skip to main content
. 2020 Jul 23;4(14):3268–3276. doi: 10.1182/bloodadvances.2020001900

Table 3.

Predicators of OS and PFS

Outcome and variable Univariate analysis OR (95% CI) Multivariate analysis OR (95% CI) Multivariate analysis P
Cohort 1
 OS
  MTV manual, high vs low 0.25 (0.10-0.66) 0.20 (0.07-0.57) .002
  Bridging therapy, yes vs no 1.00 (0.38-2.58) 1.02 (0.39-2.69) .95
  LDH before conditioning >2×ULN vs <2×ULN 1.45 (0.56-3.73) 0.60 (0.21-1.68) .33
 PFS
  MTV manual, high vs low 0.40 (0.18-0.89) 0.30 (0.12-0.72) .007
  Bridging therapy, yes vs no 0.72 (0.30-1.70) 0.78 (0.32-1.87) .58
  LDH before conditioning >2×ULN vs <2×ULN 1.04 (0.42-2.60) 0.51 (0.18-1.43) .20
Cohort 2
 OS
  MTV manual, high vs low 0.14 (0.05-0.42) 0.18 (0.04-0.69) .01
  Bridging therapy, yes vs no 2.99 (0.85-10.43) 0.77 (0.15-3.84) .75
  LDH before conditioning >2×ULN vs <2×ULN 5.86 (2.18-15.71) 3.17 (1.07-9.40) .03
 PFS
  MTV manual, high vs low 0.29 (0.12-0.69) 0.34 (0.12-0.96) .04
  Bridging therapy, yes vs no 2.00 (0.78-5.14) 0.93 (0.29-2.93) .93
  LDH before conditioning >2×ULN vs <2×ULN 4.22 (1.59-11.22) 3.18 (1.09-9.31) .03